Cargando…
Pathological ATPergic Signaling in Major Depression and Bipolar Disorder
The mood disorders, major depression (MD) and bipolar disorder (BD), have a high lifetime prevalence in the human population and accordingly generate huge costs for health care. Efficient, rapidly acting, and side-effect-free pharmaceuticals are hitherto not available, and therefore, the identificat...
Autores principales: | Illes, Peter, Verkhratsky, Alexei, Tang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006450/ https://www.ncbi.nlm.nih.gov/pubmed/32076399 http://dx.doi.org/10.3389/fnmol.2019.00331 |
Ejemplares similares
-
Decreased Functional Connectivity in Insular Subregions in Depressive Episodes of Bipolar Disorder and Major Depressive Disorder
por: Yin, Zhiyang, et al.
Publicado: (2018) -
Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Zhou, Jiaqi, et al.
Publicado: (2021) -
Chronic Treatment with Anti-bipolar Drugs Down-Regulates Gene Expression of TRPC1 in Neurones
por: Du, Ting, et al.
Publicado: (2017) -
Surveilling microglia dampens neuronal activity: operation of a purinergically mediated negative feedback mechanism
por: Illes, Peter, et al.
Publicado: (2021) -
Different Frequency of Heschl’s Gyrus Duplication Patterns in Neuropsychiatric Disorders: An MRI Study in Bipolar and Major Depressive Disorders
por: Takahashi, Tsutomu, et al.
Publicado: (2022)